Waters shareholders approve BD Biosciences & Diagnostic Solutions business combination.
ByAinvest
Tuesday, Jan 27, 2026 4:17 pm ET1min read
WAT--
• Waters shareholders approve BD's Biosciences & Diagnostic Solutions business merger • Waters Q4 2025 financial results conference call set for Feb. 9, 2026 • Waters and BD expected to close transaction soon • Waters reports strong shareholder support for the merger • Waters to hold conference call on Feb. 9, 2026, at 8:30am ET • Waters and BD to finalize merger soon • Waters to announce Q4 2025 financial results on Feb. 9, 2026
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet